Doctor of Dentistry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Summer Lane

Dentist, Oral and Maxillofacial Surgery Las Vegas, NV Doctor of Dentistry

NPI 1558761585 CMS profile 1176412

6780 S Fort Apache Rd Ste 108, Las Vegas, NV 89148

Open in the dashboard

General payments

$3,414

68 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Summer Lane of Las Vegas, NV is reported in the CMS Open Payments database as having received $3,414 across 68 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $187 2
2023 General $190 5
2022 General $1,247 9
2021 General $725 37
2020 General $867 12
2019 General $198 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Summer Lane
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Summer Lane were reported at $0. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Summer Lane Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $198 $142 $50–$420 $163
2020 $867 $96 $36–$277 $114
2021 $725 $138 $45–$419 $132
2022 $1,247 $144 $48–$367 $149
2023 $190 $153 $55–$399 $160
2024 $187 $152 $50–$400 $164
2025 $0 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Straumann USA LLC $1,302 8 payments
  2. Zimmer Biomet Holdings, Inc. $827 17 payments
  3. Nobel Biocare USA $526 36 payments
  4. Medical Device Business Services, Inc. $341 2 payments
  5. Galderma Laboratories, L.P. $187 2 payments
  6. Stryker Corporation $182 2 payments
  7. AxoGen $49 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $2,437 61 payments
  2. Education $978 7 payments
Products named General payments · program years 2019–2024
  1. NOBELACTIVE $409 27 payments
  2. Traumaone $259 4 payments
  3. Sinus Lift Kits $121 1 payment
  4. Diem2 $118 4 payments
  5. VSP ORTHOGNATHIC $114 1 payment
  6. Tapered Screw $103 2 payments
  7. Revitalize $75 1 payment
  8. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $68 1 payment
  9. Avance Nerve Graft $49 1 payment
  10. AxoGuard Nerve Connector $49 1 payment
  11. Other $222 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

252

Median for Oral Surgery (Dentist only): 288

Drug cost

$1,269

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

26.2%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 100 $399
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 35 $339
Ibuprofen Generic 67 $264
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $210
Amoxicillin Generic 19 $58

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DYSPORT
  • Galderma Laboratories, L.P. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

68 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record